A Phase 2a trial (NCT06850727) organized as a two-part, open-label and randomized study evaluating the safety and efficacy of OD-07656 followed by vedolizumab therapy in patients with moderately to severely active UC, with primary outcomes measuring changes in the 3-component mMS from baseline to 12 weeks and treatment-emergent AEs
Increased fecal ethanol and enriched ethanol-producing gut bacteria Limosilactobacillus fermentum, Enterocloster bolteae, Mediterraneibacter gnavus and Streptococcus mutans in nonalcoholic steatohepatitis
This suggested a protective potential of the peptide against such injuries
In the UK, private prescriptions include 20% VAT, and pharmacies set their own prices on top of the cost of the medicine from Novo Nordisk
Switching medications should always be coordinated with your prescriber, and progress, including side effects, should be logged in a reliable tracker to ensure smooth transitions and minimize missed doses